TMPRSS2:ERG fusion is an early event in prostate carcinogenesis, it is absent in benign prostate hyperplasia (BPH) and in normal prostate tissues and is considered to be a diagnostic and prognostic marker for PC [18,19,20]. This evidence concerns the gene TMPRSS2 and pachyonychia congenita.